Reductions in PLP, MAG, and MBP levels have been observed in neurodegenerative diseases, such as Parkinson's and Alzheimer's disease, and in convulsions caused by brain WMD.34, 35, 36. This evidence concerns the gene MAG and Alzheimer disease.